DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ovidrel (Choriogonadotropin Alfa) - Foetal Growth Restriction - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Foetal Growth Restriction (1)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ovidrel (Choriogonadotropin Alfa) where reactions include foetal growth restriction. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Ovidrel side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Malaysia on 2012-04-05

Patient: 29 year old female

Reactions: Foetal Growth Restriction, Multiple Pregnancy, Oligohydramnios, Caesarean Section, Maternal Exposure Before Pregnancy, Foetal Death, Ovarian Hyperstimulation Syndrome, Premature Delivery

Drug(s) suspected as cause:
Leuprolide Acetate
    Indication: in Vitro Fertilisation

Puregon
    Indication: in Vitro Fertilisation

Puregon
    Indication: Gamete Intrafallopian Transfer

Ovidrel
    Indication: in Vitro Fertilisation

Cyclogest
    Indication: in Vitro Fertilisation

Cyclogest
    Indication: Gamete Intrafallopian Transfer

Leuprolide Acetate
    Indication: Gamete Intrafallopian Transfer

Ovidrel
    Indication: Gamete Intrafallopian Transfer

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017